Serum Lipid Fractions and Renal Cell Carcinoma: A Review of Current Literature

Serum Lipid Fractions and Renal Cell Carcinoma Kidney cancer is among the most common human malignancies. In 2008, 273, 518 new cases of kidney cancer were diagnosed throughout the world, representing 2.8% of the worldwide cancer incidence. In that same year, 116,368 individuals died from kidney cancer. Over 90% of all kidney cancers are of adenomatous histology (clear cell renal cell carcinoma) and arise from the renal parenchyma, while the remaining 10% are a heterogeneous group of cancers mainly arising from the renal pelvis tissue. As this smaller group is distinct from the adenomatous tumors both histologically and in terms of known risk factors, this current review will only address clear cell renal cell carcinoma (RCC).